Compare Novavax Inc (NVAX) vs First Trust Cloud Computing ETF (SKYY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs First Trust Cloud Computing ETF — how do they compare? Novavax Inc trades at $9.86 (market cap $1.62B), while First Trust Cloud Computing ETF trades at $158.14. The key difference: First Trust Cloud Computing ETF is trading nearer its 52-week high, Novavax Inc nearer its low. Which is the better fit depends on your goals.
| NVAX | SKYY | |
|---|---|---|
Market Cap | $1.62B | — |
Sector | Health | — |
52-Week High | $11.19 | $168.91 |
52-Week Low | $6.22 | $104.16 |
Enterprise Value | $1.20B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novavax (NVAX) trades at $10.19, down 0.29% today, with a bullish technical signal from moving averages but overbought RSI levels. Recent Q2 2026 earnings beat expectations, and the company raised its 2026 revenue outlook. Key developments include regulatory approvals for its updated COVID-19 vaccine in the U.S., EU, and Japan for the 2026-2027 season, alongside ongoing partnerships with Sanofi and Pfizer.
The outlook is mixed: strong analyst buy ratings (73.9%) and partnership milestones offer upside, but negative net income margins and cash flow challenges pose risks. Investors should weigh the potential from vaccine demand and adjuvant platform royalties against financial sustainability concerns and competitive pressures in the biotech sector.
SKYY, the First Trust Cloud Computing ETF, trades at $159.62, down 1.2% today, with a neutral technical signal. It offers diversified exposure to cloud infrastructure and software, benefiting from AI adoption and digital transformation trends. Recent news highlights strong infrastructure spending and AI demand driving cloud computing growth, positioning SKYY for potential long-term gains.
The outlook for SKYY is positive due to secular trends in cloud migration and AI, though risks include market volatility and sector concentration. Analyst sentiment is cautiously optimistic, with institutional interest supporting the ETF's role in technology sector allocations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About First Trust Cloud Computing ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is designed to track the performance of companies involved in the cloud computing industry.
Read more on SKYY →
